May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Bishal Gyawali: Are U.S. patients paying twice for cancer drugs?
Dec 24, 2024, 18:11

Bishal Gyawali: Are U.S. patients paying twice for cancer drugs?

Bishal Gyawali, Associate Professor at Queen’s University, shared on X:

“Are U.S. patients paying twice for cancer drug like Xtandi- first by supporting its development through taxpayer’s dollars and then by paying the highest price in the world for the same drug?”

Government Funding for the Development of Enzalutamide

Authors: Bishal Gyawali et al.

Bishal Gyawali: Are U.S. patients paying twice for cancer drugs?

Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.